Inhibition of long interspersed nuclear element-1 by nucleoside reverse transcriptase inhibitors attenuates vascular calcification
8.0
来源：
Nature
关键字：
mRNA
发布时间：
2025-10-01 11:32
摘要：
This research elucidates the role of long interspersed nuclear element-1 (LINE1) in vascular calcification (VC), demonstrating that its inhibition by nucleoside reverse transcriptase inhibitors (NRTIs) significantly mitigates VC in both animal models and a clinical cohort. The study reveals that LINE1 is upregulated in calcified arteries and that its suppression downregulates the cGAS-STING signaling pathway, reducing inflammation associated with VC. Notably, a clinical study involving 1785 participants indicates that NRTIs users have a lower incidence of VC, suggesting their potential as therapeutic agents in managing this condition.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
1.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.0
technical_barrier_competition
0.5
关键证据
NRTIs treatment significantly reduced vascular calcification incidence in a clinical study involving 1785 participants.
The study identifies LINE1 as a key factor in vascular calcification.
Inhibition of LINE1 with NRTIs alleviated vascular calcification in both in vitro and in vivo models.
真实性检查
否
AI评分总结
This research elucidates the role of long interspersed nuclear element-1 (LINE1) in vascular calcification (VC), demonstrating that its inhibition by nucleoside reverse transcriptase inhibitors (NRTIs) significantly mitigates VC in both animal models and a clinical cohort. The study reveals that LINE1 is upregulated in calcified arteries and that its suppression downregulates the cGAS-STING signaling pathway, reducing inflammation associated with VC. Notably, a clinical study involving 1785 participants indicates that NRTIs users have a lower incidence of VC, suggesting their potential as therapeutic agents in managing this condition.